Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH.

PubWeight™: 2.23‹?› | Rank: Top 2%

🔗 View Article (PMC 2677505)

Published in Neurology on January 07, 2009

Authors

L H Sansing1, S R Messe, B L Cucchiara, S N Cohen, P D Lyden, S E Kasner, CHANT Investigators

Author Affiliations

1: Hospital of the University of Pennsylvania, 3400 Spruce Street, 3 W Gates, Philadelphia, PA 19104, USA. sansingl@uphs.upenn.edu

Articles citing this

Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.87

Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care (2013) 3.65

Should anticoagulation be resumed after intracerebral hemorrhage? Cleve Clin J Med (2010) 1.53

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care (2016) 1.43

Evidence against rapid reversal of antiplatelet medications in acute intracerebral hemorrhage. Neurology (2009) 1.08

PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial. BMC Neurol (2010) 0.95

Treatment targets in intracerebral hemorrhage. Neurotherapeutics (2011) 0.89

Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies. Lancet Neurol (2013) 0.83

A meta-analysis to determine the effect on survival of platelet transfusions in patients with either spontaneous or traumatic antiplatelet medication-associated intracranial haemorrhage. BMJ Open (2012) 0.82

Up-regulation of c-Fos associated with neuronal apoptosis following intracerebral hemorrhage. Cell Mol Neurobiol (2014) 0.82

Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage. J Cereb Blood Flow Metab (2011) 0.79

Sex-related differences in primary intracerebral hemorrhage. Neurology (2016) 0.78

Association Factors for CT Angiography Spot Sign and Hematoma Growth in Korean Patients with Acute Spontaneous Intracerebral Hemorrhage : A Single-Center Cohort Study. J Korean Neurosurg Soc (2014) 0.78

Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage. Ther Adv Neurol Disord (2012) 0.77

The O-GlcNAc Modification of CDK5 Involved in Neuronal Apoptosis Following In Vitro Intracerebral Hemorrhage. Cell Mol Neurobiol (2016) 0.76

Spontaneous Intracerebral Hemorrhage: Management. J Stroke (2016) 0.75

The persisting burden of intracerebral haemorrhage: can effective treatments be found? PLoS Med (2010) 0.75

The critical care management of spontaneous intracranial hemorrhage: a contemporary review. Crit Care (2016) 0.75

RApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID-TIA): study protocol for a pilot randomised controlled trial. Trials (2013) 0.75

Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH 2. Neurology (2010) 0.75

Emergency Neurological Life Support: Intracerebral Hemorrhage. Neurocrit Care (2017) 0.75

Articles cited by this

Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol (2003) 18.01

Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 9.58

Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke (1993) 6.94

Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology (2006) 4.88

Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke (1997) 4.55

CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke (2007) 3.43

Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology (2007) 3.38

Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology (2004) 2.85

Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke (2000) 2.82

Long-term mortality after intracerebral hemorrhage. Neurology (2006) 2.71

Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology (2005) 2.02

Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke (2005) 1.90

Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90

Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke (2006) 1.79

Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75

Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke (2004) 1.70

Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke (1998) 1.58

Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage: A prospective hospital-based study in Asia. Asian Acute Stroke Advisory Panel. Stroke (1999) 1.33

Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage. J Neurol (2005) 1.17

Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke (2006) 1.03

Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology (2006) 1.01

Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage. Cerebrovasc Dis (2007) 0.97

Predictors of hematoma enlargement in patients with intracerebral hemorrhage treated with rapid administration of antifibrinolytic agents and strict blood pressure control. J Neurosurg (2007) 0.95

Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality. Fundam Clin Pharmacol (2007) 0.90

Articles by these authors

(truncated to the top 100)

Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol (1978) 75.38

Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc Natl Acad Sci U S A (1972) 57.06

Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. J Mol Biol (1980) 41.18

Construction of biologically functional bacterial plasmids in vitro. Proc Natl Acad Sci U S A (1973) 25.61

Lactose genes fused to exogenous promoters in one step using a Mu-lac bacteriophage: in vivo probe for transcriptional control sequences. Proc Natl Acad Sci U S A (1979) 22.59

In vitro gene fusions that join an enzymatically active beta-galactosidase segment to amino-terminal fragments of exogenous proteins: Escherichia coli plasmid vectors for the detection and cloning of translational initiation signals. J Bacteriol (1980) 19.04

High frequency transformation of Bacillus subtilis protoplasts by plasmid DNA. Mol Gen Genet (1979) 17.16

Transformation of Salmonella typhimurium by plasmid deoxyribonucleic acid. J Bacteriol (1974) 15.89

Recircularization and autonomous replication of a sheared R-factor DNA segment in Escherichia coli transformants. Proc Natl Acad Sci U S A (1973) 13.45

Uniform nomenclature for bacterial plasmids: a proposal. Bacteriol Rev (1976) 12.28

Non-chromosomal antibiotic resistance in bacteria. II. Molecular nature of R-factors isolated from Proteus mirabilis and Escherichia coli. J Mol Biol (1970) 11.86

Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. II. Structure of drug resistance (R) factors and F factors. J Mol Biol (1973) 11.40

Replication and transcription of eukaryotic DNA in Escherichia coli. Proc Natl Acad Sci U S A (1974) 10.51

Multiple molecular species of circular R-factor DNA isolated from Escherichia coli. Nature (1969) 9.02

Cloning, isolation, and characterization of replication regions of complex plasmid genomes. Proc Natl Acad Sci U S A (1975) 8.85

Phenotypic expression in E. coli of a DNA sequence coding for mouse dihydrofolate reductase. Nature (1978) 8.76

Site specific recA--independent recombination between bacterial plasmids: involvement of palindromes at the recombinational loci. Proc Natl Acad Sci U S A (1975) 7.60

Decay of mRNA in Escherichia coli: investigation of the fate of specific segments of transcripts. Proc Natl Acad Sci U S A (1983) 6.79

Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature (1979) 6.56

Identification and characterization of recD, a gene affecting plasmid maintenance and recombination in Escherichia coli. J Bacteriol (1986) 6.06

Gene expression in Streptomyces: construction and application of promoter-probe plasmid vectors in Streptomyces lividans. Mol Gen Genet (1982) 5.99

Replication control in a composite plasmid constructed by in vitro linkage of two distinct replicons. Nature (1976) 5.73

Transposable genetic elements and plasmid evolution. Nature (1976) 5.58

Revised interpretation of the origin of the pSC101 plasmid. J Bacteriol (1977) 5.51

Genome construction between bacterial species in vitro: replication and expression of Staphylococcus plasmid genes in Escherichia coli. Proc Natl Acad Sci U S A (1974) 5.47

Occurrence of insertion sequence (IS) regions on plasmid deoxyribonucleic acid as direct and inverted nucleotide sequence duplications. J Bacteriol (1975) 5.35

Nonchromosomal antibiotic resistance in bacteria. V. Isolation and characterization of R factor mutants exhibiting temperature-sensitive repression of fertility. J Bacteriol (1972) 4.85

Molecular and genetic studies of an R factor system consisting of independent transfer and drug resistance plasmids. J Bacteriol (1973) 4.81

Are chlamydial infections the most prevalent venereal disease? JAMA (1975) 4.79

Alignment of genetic and restriction maps of the photosynthesis region of the Rhodopseudomonas capsulata chromosome by a conjugation-mediated marker rescue technique. J Bacteriol (1983) 4.56

Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg (1969) 4.41

Cloning and characterization of EcoRI and HindIII restriction endonuclease-generated fragments of antibiotic resistance plasmids R6-5 and R6. Mol Gen Genet (1978) 4.33

Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med (1970) 4.30

Utilization of two distinct modes of replication by a hybrid plasmid constructed in vitro from separate replicons. Proc Natl Acad Sci U S A (1974) 4.27

Structure and genomic organization of the mouse dihydrofolate reductase gene. Cell (1980) 4.25

3'-end labeling of DNA with [alpha-32P]cordycepin-5'-triphosphate. Gene (1980) 4.22

Differential expression of photosynthesis genes in R. capsulata results from segmental differences in stability within the polycistronic rxcA transcript. Cell (1985) 4.15

Selected translocation of plasmid genes: frequency and regional specificity of translocation of the Tn3 element. J Bacteriol (1977) 4.08

Partitioning of bacterial plasmids during cell division: a cis-acting locus that accomplishes stable plasmid inheritance. Cell (1980) 4.01

Isolation of catenated forms of R factor DNA from minicells. Nat New Biol (1971) 3.99

Indirect selection of bacterial plasmids lacking identifiable phenotypic properties. J Bacteriol (1975) 3.88

Cloning and analysis of strong promoters is made possible by the downstream placement of a RNA termination signal. Proc Natl Acad Sci U S A (1981) 3.77

Isolation of histone genes from unfractionated sea urchin DNA by subculture cloning in E. coli. Nature (1975) 3.70

Involvement of multiple translocating DNA segments and recombinational hotspots in the structural evolution of bacterial plasmids. J Mol Biol (1976) 3.63

Cloning and endonuclease mapping of the hepatitis B viral genome. Nature (1979) 3.62

Letter: Potential biohazards of recombinant DNA molecules. Science (1974) 3.45

Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke (2000) 3.44

Penicillinase-producing Neisseria gonorrhoeae. Lancet (1976) 3.37

A sensitive radioimmunoassay for detecting products translated from cloned DNA fragments. Cell (1978) 3.30

Hemorrhagic fevers of Southeast Asia and South America: a comparative appraisal. Prog Med Virol (1967) 3.22

Growth-rate dependent regulation of mRNA stability in Escherichia coli. Nature (1984) 3.06

Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2004) 2.93

Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell (1996) 2.92

Studies of mouse mitochondrial DNA in Escherichia coli: structure and function of the eucaryotic-procaryotic chimeric plasmids. Cell (1975) 2.80

The stability of E. coli gene transcripts is dependent on determinants localized to specific mRNA segments. Cell (1986) 2.79

Non-chromosomal antibiotic resistance in bacteria. 3. Isolation of the discrete transfer unit of the R-factor R1. Proc Natl Acad Sci U S A (1970) 2.76

In vivo site-specific genetic recombination promoted by the EcoRI restriction endonuclease. Proc Natl Acad Sci U S A (1977) 2.74

Nucleotide sequences encoding and promoting expression of three antibiotic resistance genes indigenous to Streptomyces. Mol Gen Genet (1985) 2.71

Coryneform bacterial endocarditis: difficulties in diagnosis and treatment, presentation of three cases, and review of literature. Mayo Clin Proc (1977) 2.63

Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study. Neurology (2011) 2.62

The usefulness of preoperative laboratory screening. JAMA (1985) 2.55

An intercistronic stem-loop structure functions as an mRNA decay terminator necessary but insufficient for puf mRNA stability. Cell (1988) 2.53

Global analysis of growth phase responsive gene expression and regulation of antibiotic biosynthetic pathways in Streptomyces coelicolor using DNA microarrays. Genes Dev (2001) 2.49

Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, 1964. J Pediatr (1966) 2.45

Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke (1999) 2.41

A+U content rather than a particular nucleotide order determines the specificity of RNase E cleavage. J Biol Chem (1994) 2.39

Identification and characterization of a self-regulated repressor of translocation of the Tn3 element. Proc Natl Acad Sci U S A (1979) 2.37

Translocation specificity of the Tn3 element: characterization of sites of multiple insertions. Cell (1980) 2.31

Structural and functional analysis of cloned DNA segments containing the replication and incompatibility regions of a miniplasmid derived from a copy number mutant of NR1. J Bacteriol (1979) 2.29

Complete nucleotide sequence of the Streptomyces lividans plasmid pIJ101 and correlation of the sequence with genetic properties. J Bacteriol (1988) 2.29

The rate of processing and degradation of antisense RNAI regulates the replication of ColE1-type plasmids in vivo. Cell (1991) 2.27

Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2005) 2.26

RNA degradation in Escherichia coli regulated by 3' adenylation and 5' phosphorylation. Nature (1995) 2.26

Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA (2001) 2.24

Transposition protein of Tn3: identification and characterisation of an essential repressor-controlled gene product. Nature (1980) 2.24

Effect of premature termination of translation on mRNA stability depends on the site of ribosome release. Proc Natl Acad Sci U S A (1987) 2.24

Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke (1998) 2.23

Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle. Cell (1987) 2.22

Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke (1998) 2.22

Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke (1999) 2.17

Genetic recombination through protoplast fusion in Streptomyces. Nature (1977) 2.14

Spontaneous early improvement following ischemic stroke. Stroke (1995) 2.13

Prospective reliability of the STRokE DOC wireless/site independent telemedicine system. Neurology (2005) 2.08

Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology (2009) 2.07

Characterization of the structural gene and putative 5'-regulatory sequences for human proopiomelanocortin. Nature (1982) 2.04

Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology (2002) 2.02

The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell (1997) 2.02

Construction and characterization of a novel two-plasmid system for accomplishing temperature-regulated, amplified expression of cloned adventitious genes in Escherichia coli. Gene (1981) 2.01

The Escherichia coli pcnB gene promotes adenylylation of antisense RNAI of ColE1-type plasmids in vivo and degradation of RNAI decay intermediates. Proc Natl Acad Sci U S A (1993) 1.99

Structural and functional analysis of the par region of the pSC 10 1 plasmid. Cell (1984) 1.98

Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology (2007) 1.97

A DNA cloning system for interspecies gene transfer in antibiotic-producing Streptomyces. Nature (1980) 1.95

The N-terminal domain of the rne gene product has RNase E activity and is non-overlapping with the arginine-rich RNA-binding site. J Mol Biol (1996) 1.92

Structural and functional analysis of transcriptional control of the Rhodobacter capsulatus puf operon. J Bacteriol (1989) 1.92

Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation (1996) 1.89

Replication timing of DNA sequences associated with human centromeres and telomeres. Mol Cell Biol (1990) 1.89

A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Proc Natl Acad Sci U S A (2001) 1.88

Excision of chromosomal DNA sequences from Streptomyces coelicolor forms a novel family of plasmids detectable in Streptomyces lividans. Mol Gen Genet (1981) 1.88

Role of DNA in RNA synthesis. XI. Selective transcription of gamma DNA segments in vitro by RNA polymerase of Escherichia coli. J Mol Biol (1967) 1.87

An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis Study. Stroke (1996) 1.86